[HTML][HTML] Adapting liposomes for oral drug delivery

H He, Y Lu, J Qi, Q Zhu, Z Chen, W Wu - Acta pharmaceutica sinica B, 2019 - Elsevier
Liposomes mimic natural cell membranes and have long been investigated as drug carriers
due to excellent entrapment capacity, biocompatibility and safety. Despite the success of …

Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview

J Zhao, J Yang, Y Xie - International journal of pharmaceutics, 2019 - Elsevier
Although flavonoid compounds have various pharmacological applications, they generally
exhibit low oral bioavailability due to their poor aqueous solubility. To address this problem …

Advances and limitations of drug delivery systems formulated as eye drops

C Jumelle, S Gholizadeh, N Annabi, R Dana - Journal of Controlled …, 2020 - Elsevier
Topical instillation of eye drops remains the most common and easiest route of ocular drug
administration, representing the treatment of choice for many ocular diseases. Nevertheless …

[HTML][HTML] Formulation, stabilisation and encapsulation of bacteriophage for phage therapy

DJ Malik, IJ Sokolov, GK Vinner, F Mancuso… - Advances in colloid and …, 2017 - Elsevier
Against a backdrop of global antibiotic resistance and increasing awareness of the
importance of the human microbiota, there has been resurgent interest in the potential use of …

Anticancer activity of chitosan, chitosan derivatives, and their mechanism of action

HS Adhikari, PN Yadav - International Journal of Biomaterials, 2018 - Wiley Online Library
Tailoring of chitosan through the involvement of its amino, acetamido, and hydroxy groups
can give derivatives of enhanced solubility and remarkable anticancer activity. The general …

Bioavailability of bioactive peptides derived from food proteins across the intestinal epithelial membrane: A review

Q Xu, H Hong, J Wu, X Yan - Trends in Food Science & Technology, 2019 - Elsevier
Abstract Background Bioactive peptides (BAPs) play a crucial physiological role in human
health. To exert their biological effects after oral administration, BAPs have to be transported …

Basics and recent advances in peptide and protein drug delivery

BJ Bruno, GD Miller, CS Lim - Therapeutic delivery, 2013 - Taylor & Francis
While the peptide and protein therapeutic market has developed significantly in the past
decades, delivery has limited their use. Although oral delivery is preferred, most are …

Polysaccharides as potential anti-tumor biomacromolecules—a review

R Guo, M Chen, Y Ding, P Yang, M Wang… - Frontiers in …, 2022 - frontiersin.org
Cancer, as one of the most life-threatening diseases, has attracted the attention of
researchers to develop drugs with minimal side effects. The bioactive macromolecules, such …

Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications

Y Kawabata, K Wada, M Nakatani, S Yamada… - International journal of …, 2011 - Elsevier
The poor oral bioavailability arising from poor aqueous solubility should make drug research
and development more difficult. Various approaches have been developed with a focus on …

Intestinal permeation enhancers for oral peptide delivery

S Maher, RJ Mrsny, DJ Brayden - Advanced drug delivery reviews, 2016 - Elsevier
Intestinal permeation enhancers (PEs) are one of the most widely tested strategies to
improve oral delivery of therapeutic peptides. This article assesses the intestinal permeation …